ABCp for Lower Back Pain

Phase-Based Progress Estimates
Lower Back PainABCp - Other
All Sexes
What conditions do you have?

Study Summary

This trial is testing whether a new approach to managing low back pain will decrease healthcare resource utilization and improve quality of life.

Eligible Conditions
  • Lower Back Pain

Treatment Effectiveness

Effectiveness Progress

1 of 3

Study Objectives

1 Primary · 2 Secondary · Reporting Duration: Through study completion, an average of 30 months

Month 30
GP ordered LBP imaging
GP requested specialist consultations
Primary Care visits

Trial Safety

Safety Progress

2 of 3
This is further along than 68% of similar trials

Trial Design

2 Treatment Groups

Usual Care
1 of 2
1 of 2

Active Control

Experimental Treatment

240 Total Participants · 2 Treatment Groups

Primary Treatment: ABCp · No Placebo Group · Phase 2

Experimental Group · 1 Intervention: ABCp · Intervention Types: Other
Usual Care
ActiveComparator Group · 1 Intervention: Usual Care · Intervention Types: Other

Trial Logistics

Trial Timeline

Screening: ~3 weeks
Treatment: Varies
Reporting: through study completion, an average of 30 months

Who is running the clinical trial?

University of AlbertaLead Sponsor
818 Previous Clinical Trials
376,574 Total Patients Enrolled
Canadian Chiropractic Research FoundationUNKNOWN
Bone and Joint Health SCNUNKNOWN
Brandyn Powelske, MScPTStudy DirectorUniversity of Alberta

Eligibility Criteria

Age 18+ · All Participants · 7 Total Inclusion Criteria

Mark “Yes” if the following statements are true for you:
You are aged at least 18 years.
For the CPC site specifically: additional requirement of depression and anxiety as rated using the PHQ4 exclusion will include score of 3 or greater on the first two questions combined and/or score of 3 or greater on the third and 4th question combined.

Who else is applying?

How old are they?
18 - 65100.0%
What site did they apply to?
University of Alberta100.0%
What portion of applicants met pre-screening criteria?
Met criteria100.0%